NovoSeven® RT is proven effective to treat FVIId at home and is 93% effective at stopping nonsurgical and surgical bleeds in people with FVIId.a
Controls bleeds, wherever they happen.
aFrom an analysis of published cases and people who took part in trials and registries.
Effectively control bleeds.
90% efficacy in bleed control in trial patients.
Portability that fits an active lifestyle.
NovoSeven® RT is room temperature stable up to 77°F, so you can be on the go.b And, with compact packaging, you can take it along where you need to go.
bNovoSeven® RT should be stored between 36°F and 77°F.
For complete storage information, please see Prescribing Information.
Quick to mix.c
NovoSeven® RT with MixPro® makes mixing a dose as easy as attach, twist, and mix. The prefilled syringe saves time—there are no extra steps to fill a syringe with diluent.
After mixing, NovoSeven® RT may be stored at room temperature in the vial for up to 3 hours.
cCompared with mixing using histidine vials.
Fast to infuse.
NovoSeven® RT provides low infusion volume, so infusing takes 2 to 5 minutes.d NovoSeven® RT is given as an intravenous (IV) bolus injection.
dAdminister as a slow bolus injection over 2 to 5 minutes, depending on the dose administered.
Established safety profile that comes from experience.e
eCompassionate use, also known as expanded access, began enrolling in 1988; FDA approval received in 1999.
What if I need surgery or a procedure?
We understand that you have concerns about controlling bleeds if you ever need surgery or a procedure. The good news is that NovoSeven® RT prevents bleeds during and after surgery and procedures in people with FVIId.
Talk to your doctor for more information on the surgical use of NovoSeven® RT.